Table 2.
Higher baseline lymphocytes were associated with larger improvement in ΔP-PANSS following ECT
| Variables | β | P value | 95% CI for β | |
|---|---|---|---|---|
| Lower | upper | |||
| age | 0.043 | 0.608 | -0.125 | 0.211 |
| gender | -0.514 | 0.734 | -3.527 | 2.499 |
| BMI | 0.238 | 0.209 | -0.137 | 0.613 |
| Education(years) | -0.346 | 0.117 | -0.780 | 0.089 |
| Duration of illness(months) | -0.005 | 0.486 | -0.020 | 0.009 |
| Chlorpromazine equivalent doses | -0.007 | 0.030 | -0.012 | -0.001 |
| Lymphocytes (10^9/L) | 23.032 | 0.007 | 6.676 | 39.388 |
Abbreviations: CI, Confidence Interval; Δ P-PANSS, Response to ECT in terms of positive symptom was measured as the variation of P-PANSS from pre-ECT to post-ECT. Values are bolded when the p-value <= 0.05